TY - JOUR
T1 - Syntheses of cytosporones A, C, J, K, and N, metabolites from medicinal fungi
AU - Beekman, Andrew M.
AU - Barrow, Russell A.
N1 - Publisher Copyright:
© 2015 CSIRO.
PY - 2015
Y1 - 2015
N2 - The syntheses of the fungal metabolites cytosporones A, (±)-C, and N are reported. And the syntheses of cytosporones J and K are described for the first time. The preparation of racemic cytosporone J and racemic cytosporone K, natural products containing the rare 3-isochromanone substructure, was achieved in 8 linear steps with an overall yield of 45% and 7 linear steps in 46% yield, respectively, resulting in the complete characterization of these compounds for the first time. The key steps included a recently described homologation of benzoic acid to the analogous phenyl acetate using Birch reductive alkylation conditions, acylation of the appropriate phenyl acetate derivative, and a selective reduction and spontaneous biomimetic lactonization to yield the 3-isochromanone skeleton. The synthesized natural products were evaluated for their biological activity against several clinical strains of human pathogens with all compounds displaying weak antimicrobial activity.
AB - The syntheses of the fungal metabolites cytosporones A, (±)-C, and N are reported. And the syntheses of cytosporones J and K are described for the first time. The preparation of racemic cytosporone J and racemic cytosporone K, natural products containing the rare 3-isochromanone substructure, was achieved in 8 linear steps with an overall yield of 45% and 7 linear steps in 46% yield, respectively, resulting in the complete characterization of these compounds for the first time. The key steps included a recently described homologation of benzoic acid to the analogous phenyl acetate using Birch reductive alkylation conditions, acylation of the appropriate phenyl acetate derivative, and a selective reduction and spontaneous biomimetic lactonization to yield the 3-isochromanone skeleton. The synthesized natural products were evaluated for their biological activity against several clinical strains of human pathogens with all compounds displaying weak antimicrobial activity.
UR - http://www.scopus.com/inward/record.url?scp=84943624471&partnerID=8YFLogxK
U2 - 10.1071/CH15144
DO - 10.1071/CH15144
M3 - Article
SN - 0004-9425
VL - 68
SP - 1583
EP - 1592
JO - Australian Journal of Chemistry
JF - Australian Journal of Chemistry
IS - 10
ER -